SCHEMBL4612485

SCHEMBL4612485

C#Cc1cnn(CC)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25359893 0.84 L3MBTL1 (0.47)
SCHEMBL19986192 0.81 L3MBTL1 (0.38)
SCHEMBL7462189 0.79
SCHEMBL4612279 0.79 ACHE (0.45)
SCHEMBL30911491 0.76 MAPT (0.33)
SCHEMBL30911847 0.76 FLT3 (0.34)
SCHEMBL15904517 0.75 KMT2A (0.35)
SCHEMBL12492676 0.75 LRRK2 (0.33)
SCHEMBL30911521 0.75 ACHE (0.35)
SCHEMBL20713609 0.75 GBA1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4328228-A1 HETEROCYCLIC COMPOUND FOR INHIBITING SHP2 ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2024-02-28 EP disclosed
EP-1476423-B1 ARYLSULFONAMIDOBENZYLIC COMPOUNDS AMGEN INC (US) 2008-10-15 EP disclosed
US-7326812-B2 Lipid diseases; metabolism diosrders; antiproliferative agents AMGEN INC. (US) 2008-02-05 US disclosed
US-7071358-B2 Arylsulfonamidobenzylic compounds AMGEN INC. (US) 2006-07-04 US disclosed
US-20060122239-A1 Arylsulfonamidobenzylic compounds TULARIK INC. 2006-06-08 US disclosed
EP-1476423-A4 ARYLSULFONAMIDOBENZYLIC COMPOUNDS TULARIK INC (US) 2005-12-14 EP disclosed
EP-1476423-A2 ARYLSULFONAMIDOBENZYLIC COMPOUNDS Tularik Inc. (US) 2004-11-17 EP disclosed
US-20030229093-A1 Arylsulfonamidobenzylic compounds TULARIK INC. 2003-12-11 US disclosed
WO-2003063576-A2 ARYLSULFONAMIDOBENZYLIC COMPOUNDS TULARIK INC. (US) 2003-08-07 WO disclosed